I agree on sales. It sounded like they missed out on capital sales (vs. recurring from disposables) due to covid in Japan and China.
They hope to have 50 installations by end of 2023 and 75 by end of 2024. They are seeing 5% per month growth in usage. That will add up fast. They have cash into Q1 2025. The new AI software they have applied for approval for is supposed to shorten the planning time for a procedure and add confidence. He didn't say it but shortening the planning time means you can do more procedures imo which should further expand growth and revenue. CEO did say he thought the 5% growth per month might accelerate in 2nd half of this year.
CPT meeting in May and if approved should get the CPT code in Q1 2025.
Had to jump off around 5 so will listen to the recording for the rest. They were in Q&A at the time with RJ analyst.